IF by specialty › Hematology
Transplantation and Cellular Therapy — Impact Factor
The 2025 Impact Factor of Transplantation and Cellular Therapy is 4.7 (Q1 in Hematology; subscription or hybrid).
- Impact Factor
- 4.7 JCR 2025
- JCR category
- Hematology
- Quartile
- Q1 in Hematology
- Publisher
- Elsevier (ASTCT)
- Open access
- subscription or hybrid
- IF source
- sciencedirect.com
Position within the field
Ranked 21 of the 38 journals in Hematology on this site (bottom 50%).
Hematology journals with a similar Impact Factor
- Journal of Thrombosis and Haemostasis IF 5.2
- Bone Marrow Transplantation IF 5.1
- Stem Cells IF 4.8
- Journal of Cerebral Blood Flow and Metabolism IF 4.7
- Cytotherapy IF 4.5
- Seminars in Hematology IF 4.3
About this value
The Journal Impact Factor of Transplantation and Cellular Therapy (JCR 2025, released June 2026) is 4.7. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Hematology.